Eduardo Ochoa-Gonzalez

610 University Ave
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Factors influencing care for patients with gynecologic malignancies from culturally and linguistically diverse backgrounds: a questionnaire study (iCALD-2).

Factors influencing care for patients with gynecologic malignancies from culturally and linguistically diverse backgrounds: a questionnaire study (iCALD-2).

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: November 20, 2025

Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer.

Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: December 02, 2024

Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancers.

Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancers.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 31, 2024

HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring.

HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Published: March 04, 2024

Heterogeneity and treatment landscape of ovarian carcinoma.

Heterogeneity and treatment landscape of ovarian carcinoma.

Journal: Nature reviews. Clinical oncology

Published: September 04, 2023

A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.

A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 28, 2023

Emerging peptide therapeutics for the treatment of ovarian cancer.

Emerging peptide therapeutics for the treatment of ovarian cancer.

Journal: Expert opinion on emerging drugs

Published: June 07, 2023

An Attempt to Stretch the Benefit: Rechallenge with PARP Inhibitors in Ovarian Cancer.

An Attempt to Stretch the Benefit: Rechallenge with PARP Inhibitors in Ovarian Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 04, 2023

Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression.

Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 20, 2023

Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer.

Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer.

Journal: Clinical Medicine Insights. Oncology

Published: March 09, 2023

Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management Challenges.

Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management Challenges.

Journal: International journal of women's health

Published: September 17, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026